BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sarvestani SK, Signs S, Hu B, Yeu Y, Feng H, Ni Y, Hill DR, Fisher RC, Ferrandon S, DeHaan RK, Stiene J, Cruise M, Hwang TH, Shen X, Spence JR, Huang EH. Induced organoids derived from patients with ulcerative colitis recapitulate colitic reactivity. Nat Commun 2021;12:262. [PMID: 33431859 DOI: 10.1038/s41467-020-20351-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Taelman J, Diaz M, Guiu J. Human Intestinal Organoids: Promise and Challenge. Front Cell Dev Biol 2022;10:854740. [DOI: 10.3389/fcell.2022.854740] [Reference Citation Analysis]
2 Pinto-Sanchez MI, Silvester JA, Lebwohl B, Leffler DA, Anderson RP, Therrien A, Kelly CP, Verdu EF. Society for the Study of Celiac Disease position statement on gaps and opportunities in coeliac disease. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34526700 DOI: 10.1038/s41575-021-00511-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ojo BA, VanDussen KL, Rosen MJ. The Promise of Patient-Derived Colon Organoids to Model Ulcerative Colitis. Inflamm Bowel Dis 2021:izab161. [PMID: 34251431 DOI: 10.1093/ibd/izab161] [Reference Citation Analysis]
4 Zhou J, Wu H, Hou J, Wang J, Wang J, Li M, Yao X, Gao J, Zhang Q. Daurisoline alleviated experimental colitis in vivo and in vitro: Involvement of NF-κB and Wnt/β-Catenin pathway. Int Immunopharmacol 2022;108:108714. [PMID: 35366641 DOI: 10.1016/j.intimp.2022.108714] [Reference Citation Analysis]
5 Verdu EF, Schuppan D. Co-factors, Microbes, and Immunogenetics in Celiac Disease to Guide Novel Approaches for Diagnosis and Treatment. Gastroenterology 2021;161:1395-1411.e4. [PMID: 34416277 DOI: 10.1053/j.gastro.2021.08.016] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Caballol B, Gudiño V, Panes J, Salas A. Ulcerative colitis: shedding light on emerging agents and strategies in preclinical and early clinical development. Expert Opin Investig Drugs 2021;:1-16. [PMID: 34365869 DOI: 10.1080/13543784.2021.1965122] [Reference Citation Analysis]
7 Ren Y, Yang X, Ma Z, Sun X, Zhang Y, Li W, Yang H, Qiang L, Yang Z, Liu Y, Deng C, Zhou L, Wang T, Lin J, Li T, Wu T, Wang J. Developments and Opportunities for 3D Bioprinted Organoids. Int J Bioprint 2021;7:364. [PMID: 34286150 DOI: 10.18063/ijb.v7i3.364] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Günther C, Rothhammer V, Karow M, Neurath M, Winner B. The Gut-Brain Axis in Inflammatory Bowel Disease-Current and Future Perspectives. Int J Mol Sci 2021;22:8870. [PMID: 34445575 DOI: 10.3390/ijms22168870] [Reference Citation Analysis]
9 Glowacki RWP, Engelhart MJ, Ahern PP. Controlled Complexity: Optimized Systems to Study the Role of the Gut Microbiome in Host Physiology. Front Microbiol 2021;12:735562. [PMID: 34646255 DOI: 10.3389/fmicb.2021.735562] [Reference Citation Analysis]